Engineered bioluminescent influenza viruses shed light on defense against influenza virus infection (Conference Presentation)

Ling Chen

doi:10.1117/12.2291867

14 March 2018 Engineered bioluminescent influenza viruses shed light on defense against influenza virus infection (Conference Presentation)

Ling Chen

Author Affiliations +

Proceedings Volume 10479, Light-Based Diagnosis and Treatment of Infectious Diseases; 104790E (2018) https://doi.org/10.1117/12.2291867
Event: SPIE BiOS, 2018, San Francisco, California, United States

Abstract

Influenza viruses cause seasonal epidemics and frequent pandemics such as avian influenza viruses H5N1 and H7N9 that resulted in significant morbidity and fatality in humans. We engineered influenza A viruses to carry a gene encoding Gaussia luciferase (IAV-luci) while remaining replication competent. Influenza A virus has 17 serological hemagglutinin (HA) subtypes, we thus generated a series of IAV-luci with different HAs including pandemic H1/California/7/2009, avian influenza H5/Hongkong/482/1997, and H7/Anhui/1/2013. Through the detection of bioluminescent signals, we showed that: 1) Infection of animals with IAV-luci enabled real time visualization of infection status or assessment of drug treatment in living animals; 2) Cultured cells infected with as little as one IAV-luci could be detected for its bioluminescent signals. 3) Neutralizing antibodies to influenza virus from the serum of H7N9 infected patients could be detected within 6 hours for diagnosis and prediction of disease outcome; 4) Neutralizing antibodies secreted by one antibody producing B cell became detectable using IAV-luci, therefore enabled the cloning of monoclonal antibodies at single cell level. 5) An ultrasensitive microneutralization assay was developed that allows the epidemiological study for “hidden” avian influenza virus infections in human population. We believe that engineered bioluminescent influenza viruses will greatly facilitate the serological monitoring of infection, epidemicological study, antiviral drug discovery, especially the search for anti-influenza neutralizing antibodies.

Conference Presentation

Citation Download Citation

Ling Chen "Engineered bioluminescent influenza viruses shed light on defense against influenza virus infection (Conference Presentation)", Proc. SPIE 10479, Light-Based Diagnosis and Treatment of Infectious Diseases, 104790E (14 March 2018); https://doi.org/10.1117/12.2291867

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
PRESENTATION

WATCH
PRESENTATION SAVE TO MY LIBRARY

GET CITATION

KEYWORDS

Viruses

Signal detection

Drug discovery

Bioluminescence

Computer programming

Defense and security

Monoclonal antibodies

Show All Keywords

Keywords/Phrases

Search In:

Publication Years